Search

OHSU leads new psilocybin research

OHSU leads new psilocybin research

September 04, 2026

OHSU President Shereef Elnahal, M.D., M.B.A., speaks during a media availability on Aug. 19 with Todd Korthuis, M.D., M.P.H., following publication of a landmark study examining Oregon psilocybin services. Participants in the study reported relief from symptoms of anxiety, depression and post-traumatic stress disorder, with few adverse outcomes. (OHSU/Christine Torres Hicks)

OHSU leads new psilocybin research

OHSU leads new psilocybin research

September 04, 2026

Todd Korthuis, M.D., M.P.H., speaks during a media availability on Aug. 19 following publication of a landmark study into state-regulated psilocybin services in Oregon. (OHSU/Christine Torres Hicks)

Neuroimaging for early child development discoveries

Neuroimaging for early child development discoveries

September 03, 2026

Senior research assistant Samuel Carpenter places MRI equipment onto Benjamin Newman as mom, Alice Graham, MS, Ph.D., and Elinor Sullivan, Ph.D., right, look on. Sullivan and Graham demonstrate how they use a neuroimaging to discover child development problems early. (OHSU/Christine Torres Hicks)

OHSU Doernbecher Children's Hospital Fetal Care Team

OHSU Doernbecher Children's Hospital Fetal Care Team

September 03, 2026

Infants who underwent a successful in-utero surgery are visited by their surgeons, Raphael Sun, M.D., and Andrew Chon, M.D., who have expanded OHSU Doernbecher Children’s Hospital fetal care team to include treatments of babies still in the womb. (OHSU/Christine Torres Hicks)

OHSU Fetal Surgery Team

OHSU Fetal Surgery Team

September 03, 2026

Surgeons Raphael Sun, M.D., center left, holds Felix, and Andrew Chon, M.D., center right, holds Isaac, next to mom, Adriana Romero Villarreal, far left, and Romero Villarreal's partner, Isaac Bagnall., right. (OHSU/Christine Torres Hicks)

OHSU researchers now can predict severity of a rare genetic disease in children

OHSU researchers now can predict severity of a rare genetic disease in children

September 03, 2026

A team of researchers at OHSU has developed a framework to better evaluate the different types of UBA5 mutations, which cause a rare, deadly neurodegenerative disease in children. From left: Kofi Asare-Konadu, research assistant; Ruth Napier, Ph.D., assistant professor of molecular microbiology and immunology at OHSU School of Medicine; Jonathan Pruneda, Ph.D., assistant professor of molecular microbiology and immunology at OHSU School of Medicine; and Nick Alvarez, research assistant. (OHSU)

fetal surgery

fetal surgery

September 03, 2026

Andrew Chon, M.D., pays a visit to the Hungate twins after delivery. With Dr. Chons special training, OHSU Doernbecher is able to perform complex, in-utero fetal surgeries that help families like the Hungates. (Courtesy of the Hungate family)

OHSU Neonatal Intensive Care Unit (NICU)

OHSU Neonatal Intensive Care Unit (NICU)

September 03, 2026

Entrance to the Neonatal Intensive Care Unit (NICU) at Oregon Health & Science University (OHSU) on Marquam Hill in Portland, Oregon. The unit provides specialized care for newborns requiring advanced medical support. (OHSU/Christine Torres Hicks)

See More Stories